136 related articles for article (PubMed ID: 16442531)
1. Repression of SOX6 transcriptional activity by SUMO modification.
Fernández-Lloris R; Osses N; Jaffray E; Shen LN; Vaughan OA; Girwood D; Bartrons R; Rosa JL; Hay RT; Ventura F
FEBS Lett; 2006 Feb; 580(5):1215-21. PubMed ID: 16442531
[TBL] [Abstract][Full Text] [Related]
2. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
[TBL] [Abstract][Full Text] [Related]
3. Induction of the Sry-related factor SOX6 contributes to bone morphogenetic protein-2-induced chondroblastic differentiation of C3H10T1/2 cells.
Fernández-Lloris R; Viñals F; López-Rovira T; Harley V; Bartrons R; Rosa JL; Ventura F
Mol Endocrinol; 2003 Jul; 17(7):1332-43. PubMed ID: 12677004
[TBL] [Abstract][Full Text] [Related]
4. Repression of Smad4 transcriptional activity by SUMO modification.
Long J; Wang G; He D; Liu F
Biochem J; 2004 Apr; 379(Pt 1):23-9. PubMed ID: 14750902
[TBL] [Abstract][Full Text] [Related]
5. SUMO E3 ligase activity of TRIM proteins.
Chu Y; Yang X
Oncogene; 2011 Mar; 30(9):1108-16. PubMed ID: 20972456
[TBL] [Abstract][Full Text] [Related]
6. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
[TBL] [Abstract][Full Text] [Related]
7. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
[TBL] [Abstract][Full Text] [Related]
8. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
[TBL] [Abstract][Full Text] [Related]
9. SUMOylation modulates transcriptional repression by TRPS1.
Kaiser FJ; Lüdecke HJ; Weger S
Biol Chem; 2007 Apr; 388(4):381-90. PubMed ID: 17391059
[TBL] [Abstract][Full Text] [Related]
10. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
Ihara M; Yamamoto H; Kikuchi A
Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
[TBL] [Abstract][Full Text] [Related]
11. Solubility shift and SUMOylaltion of promyelocytic leukemia (PML) protein in response to arsenic(III) and fate of the SUMOylated PML.
Hirano S; Tadano M; Kobayashi Y; Udagawa O; Kato A
Toxicol Appl Pharmacol; 2015 Sep; 287(3):191-201. PubMed ID: 26049103
[TBL] [Abstract][Full Text] [Related]
12. Toward understanding the functions of the two highly related Sox5 and Sox6 genes.
Lefebvre V
J Bone Miner Metab; 2002; 20(3):121-30. PubMed ID: 11984693
[No Abstract] [Full Text] [Related]
13. Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.
Xu Y; Ahn JH; Cheng M; apRhys CM; Chiou CJ; Zong J; Matunis MJ; Hayward GS
J Virol; 2001 Nov; 75(22):10683-95. PubMed ID: 11602710
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA binding by differential sumoylation of heat shock factors.
Anckar J; Hietakangas V; Denessiouk K; Thiele DJ; Johnson MS; Sistonen L
Mol Cell Biol; 2006 Feb; 26(3):955-64. PubMed ID: 16428449
[TBL] [Abstract][Full Text] [Related]
15. Identification of two independent SUMO-interacting motifs in Daxx: evolutionary conservation from Drosophila to humans and their biochemical functions.
Santiago A; Godsey AC; Hossain J; Zhao LY; Liao D
Cell Cycle; 2009 Jan; 8(1):76-87. PubMed ID: 19106612
[TBL] [Abstract][Full Text] [Related]
16. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
[TBL] [Abstract][Full Text] [Related]
17. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
[TBL] [Abstract][Full Text] [Related]
18. Regulation of nuclear receptor and coactivator functions by the carboxyl terminus of ubiquitin-conjugating enzyme 9.
Chang YL; Huang CJ; Chan JY; Liu PY; Chang HP; Huang SM
Int J Biochem Cell Biol; 2007; 39(5):1035-46. PubMed ID: 17336575
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.
Lehembre F; Müller S; Pandolfi PP; Dejean A
Oncogene; 2001 Jan; 20(1):1-9. PubMed ID: 11244500
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
Nakagawa K; Kuzumaki N
Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
